Clinical trial
UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical…
NCT00003598 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003598 |
|---|---|
| Title | UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia |
| Official title | Retinoids and Intermediate Biomarkers for CIN II and III: Pilot Trial |
| Acronym | IRB 1996-0189 |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cervical Cancer, Precancerous/Nonmalignant Condition |
| Intervention type | Drug |
| Interventions | tretinoin |
| Enrollment | 180 |
| Start date | Jan 1, 1999 |
| Primary completion | Mar 1, 2001 |
| Completion | Nov 1, 2009 |
| First posted | Dec 5, 2003 |
| Last update posted | Sep 22, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: